Puma Biotechnology Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (29)

Latest Posts

About This Stock More About This Stock
Puma Biotech: Is It Time For This Kitty To Roar?
Article By: TipRanks
Wednesday, October 10, 2018 10:29 PM EST
Puma is an oncology company with drug Nerlynx approved for HER2 positive adjuvant breast cancer. But the market has yet to appreciate the drug’s full potential.
In this article: PBYI
Read
Week In Review: C-Bridge Raising Another $650 Million For China Healthcare
Article By: ChinaBio® Today
Saturday, February 3, 2018 4:43 PM EST
Shanghai's C-Bridge Capital is raising capital for its third healthcare private equity fund with a target of $650 million (see story). Just six months ago, C-Bridge closed its second PE fund at a hard cap of $400 million.
In this article: CASI, SRNE, PBYI
Read
4 Biotech Stocks That More Than Doubled This Year
Article By: Zacks Investment Research
Saturday, December 23, 2017 7:50 PM EST
The biotech industry has been on the comeback trail in 2017 after facing challenges including pricing pressure, rising competition, pipeline setbacks, pricing pressure, slowdown in growth of mature products and generic competition for key drugs.
In this article: JUNO, BLUE, XOMA, PBYI, PIRS, ALNY Also: CELG
Read
JPMorgan Ups Puma Target To $131 After Surveying 25 Oncologists
Article By: The Fly
Wednesday, October 4, 2017 7:18 AM EST
JPMorgan analyst Cory Kasimov believes shares still have upside potential as Nerlynx's sales trajectory "appears underappreciated." The analyst reiterates an Overweight rating on Puma shares.
In this article: PBYI
Read
XBI Breaks Through On A Strong Week For Biotech
Article By: Rod Raynovich
Friday, September 29, 2017 7:25 PM EST
The XBI is up 3.17% this week, 46% YTD, compared to only 1.1% WTD for the IBB. The breakthrough gains for the XBI can be attributed to strong performance of top ten holdings that are primarily mid-caps and M&A prospects.
In this article: BMY, ALNY, BMRN, IBB, AMGN, CELG, CLVS, XBI, JUNO, PBYI, SRPT, BLUE, PTCT, ABBV, FMI
Read

PARTNER HEADLINES

Latest Tweets for $PBYI

No tweets yet!